This fall and winter, Ontario, Quebec and Nunavut will offer nirsevimab — approved by Health Canada in the spring of 2023 —  to all babies going through their first RSV season.

The treatment provides protective antibodies to infants. It will be available to all Ontario babies born in 2024 as well as ...

In a significant public health initiative, the Illinois Academy of Family Physicians (IAFP) has joined forces with the ...

Adults and children alike should self-isolate if they have symptoms of COVID-19. They should remain home until their symptoms ...

Recently, a resident of Brantford-Brant, Ontario, Canada, was also confirmed with bat-bite ... Individuals who have already received an RSV vaccine do not need additional doses, and vaccination is not ...

A former Lethbridge pastor who bilked millions out of hundreds of southern Albertans has appealed his conviction and sentence ...

An Edmonton club promoter who sexually assaulted five women has had his day parole continued. Matthew McKnight was granted ...

A Verner man, 35, is charged in connection with a fatal crash on Highway 17 last month that killed one and sent another to ...

Windsor Mayor Drew Dilkens said that homeowners will see large cost-savings in the future, "because what we're doing is ...

Health care is shaping up to be a major issue for this fall’s provincial election in Saskatchewan and on Monday both the Sask ...

The CDC just released new recommendations for the shot in June 2024, focusing on folks that are 60 or older, who are ...

In the 2023 to 2024 respiratory syncytial virus (RSV) season, more than half of infants were protected by maternal RSV ...